A method of reducing virulence in a bacterium comprising at least one of a GacS/GacA-type system, a HrpX/HrpY-type system, a T3SS-type system, and a Rsm-type system, the method comprising contacting the bacterium with an effective amount of a compound described herein.
Compounds of the formula:
that are useful to inhibit dopamine-β-hydroxylase activity, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use as inhibitors of dopamine-β-hydroxylase activity in mammals.